netFormulary NHS
Coastal West Sussex
Local Health Economy Formulary
 Search
 Formulary Chapter 5: Infections - Full Section
Notes:

Traffic lights have been assigned to these drugs, although there are additional recommendations on what grade of staff may initiate or recommend them within secondary care. Please refer to WSHfT Antimicrobial Guidelines for such information before prescribing any of these antimicrobials.

CWS CCG prescribers should refer to the Antibiototic Guidelines for the Management of infections in Primary Care.

For further guidance refer to local Consultant Microbiologists:
Medical Microbiologist: 01903 205111 ext 5569 (W&S), 01243 788122 ext 3547 (SRH)

Surrey and Sussex Health Protection Unit
Tel: 0845 8942944

When initiating therapy with agents marked with Restricted Item  'RESTRICTED' you must seek Microbiology/Infectious Diseases advice.

Unless otherwise stated, doses are oral and for adults only. Please refer to the BNF/BNFC for further information.

Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
05.01 Antibacterial drugs (0,0)
05.01.01 Penicillins (0,0)
05.01.01.01 Benzylpenicillin and phenoxymethylpenicillin (4,0)
05.01.01.02 Penicillinase-resistant penicillins (2,0)
05.01.01.03 Broad-spectrum penicillins (3,5)
05.01.01.04 Antipseudomonal penicillins (2,0)
05.01.01.05 Mecillinams (1,0)
05.01.02 Cephalosporins, carbapenems and other beta-lactums (0,4)
05.01.02.01 Cephalosporins (9,8)
05.01.02.02 Carbapenems (2,3)
05.01.02.03 Other beta-lactums antibiotics (2,0)
05.01.03 Tetracyclines (5,10)
Tigecycline (1,0)
05.01.04 Aminoglycosides (7,4)
05.01.05 Macrolides (5,8)
05.01.06 Clindamycin (1,0)
05.01.07 Some other antibacterials (1,2)
Chloramphenicol (1,1)
Fusidic acid (1,0)
Vancomycin and teicoplanin (2,1)
Daptomycin (1,0)
Linezolid (1,0)
Quinupristin and dalfopristin (0,0)
Polymyxins (4,0)
Rifaximin (1,0)
Fidaxomicin (1,0)
05.01.08 Sulphonamides and trimethoprim (2,2)
05.01.09 Antituberculosis drugs (12,2)
05.01.10 Antileprotic drugs (1,1)
05.01.11 Metronidazole and tinidazole (2,3)
05.01.12 Quinolones (5,4)
05.01.13 Urinary-tract infections (4,3)
05.02 Antifungal drugs (0,0)
Treatment of fungal infections (0,0)
Drugs used in fungal infections (0,1)
05.02.01 Triazole antifungals (4,0)
05.02.02 Imidazole antifungals (0,0)
05.02.03 Polyene antifungals (3,0)
05.02.04 Echinocandin antifungals (1,2)
05.02.05 Other antifungals (4,0)
05.03 Antiviral drugs (0,0)
05.03.01 HIV infection (0,0)
Nucleoside reverse transcriptase inhibitors (15,0)
Protease inhibitors (8,0)
Non-nucleoside reverse transcriptase inhibitors (5,0)
Other antiretrovirals (3,0)
05.03.02 Herpesvirus infections (0,0)
05.03.02.01 Herpes simplex and varicella-zoster infection (3,3)
05.03.02.02 Cytomegalovirus infrection (5,0)
05.03.03 Viral hepatitis (0,0)
05.03.03.01 Chronic hepatitis B (3,1)
05.03.03.02 Chronic hepatitis C (11,0)
05.03.04 Influenza (3,1)
05.03.05 Respiratory syncytial virus (5,0)
05.04 Antiprotozoal drugs (0,0)
05.04.01 Antimalarials (0,0)
Treatment of malaria (0,0)
Falciparum malaria (treatment) (0,0)
Benign malarias (treatment) (0,0)
Prophylaxis against malaria (0,0)
Specific recommendations (1,0)
Artemether with lumefantrine (1,0)
Chloroquine (1,4)
Mefloquine (1,0)
Primaquine (1,0)
Proguanil (2,2)
Pyrimethamine (1,1)
Quinine (1,0)
Tetracyclines (1,0)
05.04.02 Amoebicides (2,0)
05.04.03 Trichomonacides (2,0)
05.04.04 Antigiardial drugs (1,0)
05.04.05 Leishmaniacides (1,0)
05.04.06 Trypanocides (0,0)
05.04.07 Drugs for toxoplasmosis (0,0)
05.04.08 Drugs for pneumocystis pneumonia (3,0)
Treatment (0,0)
Prophylaxis (0,0)
05.05 Anthelmintics (0,0)
05.05.01 Drugs for threadworms (2,0)
05.05.02 Ascaricides (2,1)
05.05.03 Drugs for tapeworm infections (0,0)
Taenicides (2,0)
Hydatid disease (1,0)
05.05.04 Drugs for hookworms (2,0)
05.05.05 Schistosomicides (1,0)
05.05.06 Filaricides (2,0)
05.05.07 Drugs for cutaneous larva migrans (3,0)
05.05.08 Drugs for strongyloidiasis (1,0)
netFormulary